Genmab | GEN - Umsatzerlöse

Aktienkurs
1,690.00
Täglich Wechseln
35.00 2.11%
Monatlich
-1.34%
Jährlich
20.80%
Q2 Prognose
1,628.53




Der Umsatz Veränderung Datum
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Almirall EUR 547.63M 12.83M 2025-12
Amarin USD 49.22M 451K 2025-12
Amgen USD 9.9B 340M 2025-12
argenx SE USD 1.12B 132.91M 2025-12
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 11.44B 1.78B 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Demant DKK 6.26B 810M 2025-12
Exelixis USD 598.66M 860K 2025-12
Fresenius Medical Care EUR 5.07B 180M 2025-12
Galapagos EUR 900.82M 835.52M 2025-12
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
GN Store Nord DKK 4.68B 720M 2025-12
GRIFOLS EUR 1.98B 110M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.25B 70M 2025-12
Novartis USD 13.11B 226M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12